Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array-based solutions for genetic and genomic analysis. The one-month return of Illumina, Inc. (NASDAQ:ILMN) was -32.97%, and its shares lost 34 ...
PGX's passive structure and retail investors' lack of effort lead to overvaluations; alternatives can outperform PGX with better yields and credit ratings. PGX invests in fixed-rate preferred ...
PGX's dividend yield currently ranks #7 of 22 vs. its peers in the Convertible Bond/Preferred Stock ETFs category.
BEIJING’S surprise move to blacklist Illumina has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant. While Illumina is still assessing the ...
Founded in 1998, Illumina is a genetic testing company. It develops DNA sequencing and array-based life sciences technologies to enable research discovery. Illumina sells a number of DNA sequencing ...
The film finds Renée Zellweger's now widowed character navigating modern dating and motherhood The return of Bridget Jones has earned the best box office opening ever for a romantic comedy in the ...
For the first time, China has put American genome-sequencing equipment manufacturer Illumina on its “unreliable entity list”. The move was a direct counter to the US imposing sanctions on Beijing ...
That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...
(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings ... to become a trusted provider of content for a wide array of subjects across several platforms.
China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on notice late Monday. The move is clearly a retaliatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results